Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin

NCT00048971 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT00048971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pharmacogenetic Case-Control Study of Severe Diarrhea and Life-Threatening Neutropenia in Patients Treated With Irinotecan, 5-Fluorouracil and Leucovorin
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Observational
Overall status
Completed
Start date
April 30, 2002
Completion date
November 30, 2006
Enrollment
308 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, diarrhea, neutropenia